Search
for
Sort by
Research 361–390 of 1000+
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Modern Management Approaches for Alopecia Areata
- Update: baricitinib for alopecia areata
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Tribuloside acts on the PDE/cAMP/PKA pathway to enhance melanogenesis, melanocyte dendricity and melanosome transport
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Advances in the mechanism and new therapies of alopecia areata
- An Updated in the Management of Alopecia Areata
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Ann Robinson’s research reviews —12 May 2022
- Alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Skin Cancer: Mechanisms and Human Relevance
- Alopecia areata
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Leptin and the skin: a new frontier
- Influence of prostaglandin F<sub>2α</sub> and its analogues on hair regrowth and follicular melanogenesis in a murine model
- Phospholipase C 1 is required for skin stem cell lineage commitment